5
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Reflections on Guidelines and Theories for Pharmacist-Patient Interactions

Pages 59-81 | Published online: 04 Dec 2011

REFERENCES

  • Pew Health Professions Commission. Critical challenges: revitalizing the health professions for the twenty-first century; the third report of the Pew Health Professions Commission. San Francisco, CA: UCSF Center for Health Profes-sions, 1995.
  • Svarstad BL. Development of behavioral science curricula and faculty in pharmacy: some issues requiring attention. Am J Pharm Educ. 1994; 58:177–83.
  • Gibson MR. Patient instruction by private consultation. J Am Pharm Assoc. 1966; NS6:632–34, 646.
  • Brands, Al. Complete directions for prescription medication. J Am Pharm Assoc. 1967; NS7:634–5.
  • Knapp DA, Wolf HH, Knapp DE et at. An experimental analysis. .. the pharmacist as a drug advisor..1 Am Phanrn Assoc. 1969; NS9:502–5, 543.
  • American Society of Hospital Pharmacists. Statement on pharmacist-con-ducted patient counseling. Am J Hosp Pharr., 1976; 33:644–5.
  • Beardsley RS, Johnson CA, Wise G. Privacy as a factor in patient counsel-ing. I Am Pharm Assoc. 1977; NSI7:366–8.
  • Crichton EF, Smith DL, Demanuele F. Patient recall of medication in-formation. Drug Intell Clin Pharm. 1978; 12:591–9.
  • Dickey FF, Mattar ME, Chudzik GM. Pharmacist counseling increases drug regimen compliance. Hospitals. 1975; 49(9):85–6, 88.
  • Ludy JA, Gagnon JP, Caiola SM. The patient-pharmacist interaction in two ambulatory settings-its relationship to patient satisfaction and drug misuse. Drug Intell Clin Pharm. 1977; 11:81–9.
  • Madden EE Jr. Evaluation of outpatient pharmacy patient counseling. J Am Pharm Assoc. 1973; NSI3:437–43.
  • Puckett Fl, White Si, Mossberg HE et al. Pharmacist/ patient counseling practices. Contemp Pharm Pract. 1978; 1:67–71.
  • Rowles B, Keller SM, Gavin PW. The pharmacist as compounder and con-sultant. Drug Intel] Clin Pharm. 1974; 8:242–4.
  • Sczupak CA, Conrad WF. Relationship between patient-oriented pharma-ceutical services and therapeutic outcomes of ambulatory patients with diabetes mellitus. Am Hasp Pharm. 1977; 34:1238–42.
  • Jung R, Knapp DA, Knapp DE. An evaluation of the quality of drug-re-lated services in neighborhood pharmacies. Drugs Health Care. 1975; 2:21–38.
  • Linn LS, Davis MS. Occupational orientation and overt behavior-the phar-macist as drug advisor to patients. Am) Public Health. 1973; 63:502–8.
  • Vanderveen RL, Adorns C, Sanborn M. The pharmacist as a drug consul-tant-five years later. Drug Nell Clin Pharm. 1978; 12:718–9.
  • Wertheimer Al, Sheffer E, Cooper RM. More on the pharmacist as a drug consultant. Drug Intell Clin Pharm. 1973; 7:58–61.
  • Watkins RL, Norwood al, Meister FL. Improving the quality of the phar-macist as a drug advisor to patients and physicians through continuing education. Am J Pharm Educ. 1976:40:34–9.
  • Cole P, Emmanuel Sister. Drug consultation: its significance to the dis-charged hospital patient and its relevance as a role for the pharmacist. Am J Hasp Pharm, 1971; 28:954–60.
  • Slama PJ, Gurwich EL. Effect of pharmacist consultation on medication compliance. Contemp Pharm Pract. 1978; 1:71–7.
  • Clinite IC, Kabul HF. Improving patient compliance. I Am Pharm Assoc. 1976; NS16:74–6, 85.
  • Dickson WM, Rodowskas CA Jr. Verbal communications of community pharmacists. Med Care. 1975; 13:486–98.
  • McKenney JM, Brown ED, Necsary R et at. Effect of pharmacist drug monitoring and patient education on hypertensive patients. Contemp Pharm Pract. 1978; 1:50–6.
  • McKenney JM, Slining JM, Henderson HR et al. The effect of clinical pharmacy services on patients with essential hypertension. Circulation. 1973; 48:1104–11.
  • Chubb JM, Winship HW 3rd. The pharmacist's role in preventing medica-tion errors made by cardiac and hyperlipoproteinemie outpatients. Drug Intell Clin Pharm. 1974; 8:430–6.
  • Campbell RK, Grisafe JA. Compliance with the Washington state patient information regulation. J Ann Pharm Assoc. 1975; NS15:494–5, 528.
  • Linkewich JA, Catalano RB, Flack HL. The effect of packaging and instruction on outpatient compliance with medication regimens. Drug Intell Clin Pharm. 1974; 8:10–5.
  • Covington TR, Pfeiffer PG. The pharmacist-acquired medication history. Am I Hasp Pharm. 1972; 29:692–5.
  • Grissinger SE, Wolfe LW, Cohen, MR. A protocol for consultation with discharged patients about their medications. Hosp Pharm. 1973; 8:175, 178–9, 182–3.
  • Boyd JR, Covington TR, Stanaszek WF et al. Drug defaulting, Part II: analysis of noncompliance patterns. Amer J Hasp Pharm. 1974; 31:485–91.
  • Gurwich E, Emmanuel Sister. A comprehensive health care program. JAm Pharm Assoc. 1974; NS14:71–5, 78–9.
  • Kessler DA. Communicating with patients about their medications. New Engl J Med. 1991; 325:1650–2.
  • Reeder CE. Patient medication counseling: a practical perspective. Pharm Times. 1989; 55(6):57–8, 62–4,67.
  • Molzon JA. What kinds of patient counseling are required? Am Pharm. 1992; NS32(3):50–7.
  • American Society of Hospital Pharmacists. ASHP guidelines on pharma-cist-conducted patient counseling. Am Hosp Pharm. 1984; 41:331.
  • Brushwood DB, Catizone CA, Coster JM. OBRA 1990: what it means to your practice. US Pharm. 1992; 17(10): 64–72.
  • American Society of Hospital Pharmacists. ASHP guidelines on pharma-cist-conducted patient counseling. Am I Hasp Pharm. 1993; 50:505–6.
  • Foster SL, Smith EB, Seybold MR. Advanced counseling techniques: inte-grating assessment and intervention. Am Pharm. 1995; NS35(10):40–9.
  • Leibowitz K. Improving your patient counseling skills. Am Pharm. 1993; NS33(4):65–9.
  • Berger BA, Felkey BG. Patient counseling and communication. In: Effec-tive pharmacy management: a comprehensive presentation of practical manage-ment techniques for pharmacists. 7th ed. Alexandria, VA: NARD, 1994.
  • Lunge EL, Taylor AT. Basics of patient counseling. Am Pharm. 1980; N820(6).19–20.
  • Beardsley RS. Why communication skills are important in HHC. US Pharm. 1985; 10(12): 56–8.
  • Witte KW, Bober KF. Developing a patient education program in the com-munity pharmacy. Am Pharm. 1982; NS22(10):28–32.
  • Kitching JB, Jones IF. Communicating with patients, Part 2. Asking ques-tions. Pharm J. 1990; 244:110.
  • Kitching JB, Jones IF. Communicating with patients, Part 3. Listening. Pharm J. 1990; 244:171.
  • Kitching JB, Jones IF. Communicating with patients, Part 4. Explanations. Pharm 5. 1990; 244:192–3.
  • Tindall WN, Beardsley RS, Kimberlin CL. Communication skills in phar-macy practice: a practical guide for students and practitioners. 3rd ed. Philadel-phia: Lou & Febiger; 1994.
  • Smith DL. Patient counseling: your competitive edge. Am Pharm. 1991; NS31(7):53–56.
  • Raynor DK. Patient compliance: the pharmacist's role. Int J Pharm Pract. 1992; 1:126–35.
  • Pedersen C, Schulz RM. Patient counseling: a conceptual analysis. Pharm Law Ann. 1990; 61–66.
  • Dole El. Beyond pharmaceutical care. Am S Hasp Pharm. 1994; 51:2183–4.
  • Home R. One to betoken as directed: reflections on non-adherence (non-compliance). I Soc Admix Pharm. 1993; 10;150–6.
  • Hargie OD, Morrow NC. Counselling and health care: a perspective from pharmacy. Int Pharm J. 1990; 4:255–9.
  • Morley PC. Pharmaceutical care: desiderata. I Clin Pharrn Thar. 1993; 18:143–6.
  • Covington TR, Whitney HAK Jr. Patient-pharmacist communication tech-niques. Drug Intell Clin Pharm. 1971; 5:370–6.
  • Ivey M, Tso V Stamm K. Communication techniques for patient instruc-tion. Am .1 Hasp Pharm. 1975; 32:828–31.
  • Lively BT. Communication as a transactional process-basic tools of the community pharmacist. Contemn Pharm Pract. 1978; 1:81–5.
  • Hudmon KS, Berger BA. Pharmacy applications of the transtheoretical model in smoking cessation. Am .1 Health-System Pharm. 1995; 52:282–7.
  • Prochaska JO, Redding CA, Harlow LL et at. The transtheoretical model of change and HIV prevention: a review. Health Educ Q. 1994; 21:471–86.
  • Berger BA, Stanton AL, Felkey BC et at. Effectiveness of an educational program to teach pharmacists to counsel hypertensive patients and influence treat-ment adherence..1Pharm Mark Manage. 1990; 5:27–41.
  • Meichenbaum D, Turk DC. Facilitating treatment adherence: a practitio-ner's guidebook. New York: Plenum Press; 1987.
  • Kimberlin CL, Berardo DH, Pendergast JF clot. Community pharmacists' influence on drug therapy decisions for elderly patients. Ann Rev Gerontology Geriatrics. 1992; 12:126–49.
  • Kimberlin CL, Berardo DH, Pendergast JF at at. Effects of an education program for community pharmacists on detecting drug-related problems in elder-ly patients. Med Care. 1993; 31:451–68.
  • Lazarus AA. Multimodal behavior therapy. New York: Springer; 1976.
  • Svarstad BL. Patient-practitioner relationships and compliance with pre-scribed medical regimens. In: Aiken LH and Mechanic D, eds. Applications of social science to clinical medicine and health policy. New Brunswick, NJ: Rutgers University Press, 1986.
  • Opdycke RA, Ascione FJ, Skimp LA et al. A systematic approach to edu-cating elderly patients about their medication. Patient Educ Cowls. 1992; 19:43–60.
  • McBean-Cochran B. Information for patients. int I Pharm Pract. 1992; 1:121–2.
  • Pendleton D, Schofield T, Tate P, Havelock P. The consultation: an ap-proach to teaming and teaching. New York, NY: Oxford University Press; 1984.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.